The failure of immunosuppression withdrawal: Patient benefit is not detectable, inducible, or reproducible | Zendy

Porrett Paige | Zendy; Shaked Abraham | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

The failure of immunosuppression withdrawal: Patient benefit is not detectable, inducible, or reproducible

Author(s) -

Porrett Paige,

Shaked Abraham

Publication year - 2011

Publication title -

liver transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.814

H-Index - 150

eISSN - 1527-6473

pISSN - 1527-6465

DOI - 10.1002/lt.22377

Subject(s) - immunosuppression , medicine , intensive care medicine , nephrotoxicity , liver transplantation , transplantation , kidney

Key Points (1) Immunosuppression is responsible for excellent patient outcomes. (2) Immunosuppression withdrawal fails in most patients. (3) Patients who may benefit from immunosuppression withdrawal cannot currently be identified. (4) No data suggest that immunosuppression withdrawal decreases patient morbidity (ie, nephrotoxicity). (5) The minimization of immunosuppression instead of withdrawal may be adequate for improving patient outcomes. Liver Transpl, 2011. © 2011 AASLD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research